characteristics.text: SAMN32958848
characteristics.characteristic: External Id
characteristics.text: Dep. of Molecular Mechanisms of Disease, University of Zurich
characteristics.characteristic: INSDC center name
characteristics.text: 2023-04-14T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2023-04-14T02:29:51.810Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS16620965
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS16620965
characteristics.characteristic: SRA accession
characteristics.text: PC3 cells (prostate cancer bone metastasis)
characteristics.characteristic: cell line
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: PC3 cells (prostate cancer bone metastasis)
characteristics.characteristic: source_name
characteristics.text: PC3 + TOP2A inhibitor ICRF-193_rep2
characteristics.characteristic: title
characteristics.text: 10uM ICRF-193 for 48h
characteristics.characteristic: treatment